41
Participants
Start Date
June 29, 2018
Primary Completion Date
June 14, 2019
Study Completion Date
June 14, 2019
Naproxen Sodium (Aleve, BAY117031)
660 mg daily for 3 days, 440 mg on the fourth day, over-encapsulated tablet, oral (Treatment A)
Acetaminophen ER
3900 mg daily for 3 days, 1300 mg on the fourth day, over-encapsulated extended release (ER) tablet, oral (Treatment B)
Celecoxib
200 mg daily for 3 days, 100 mg on the fourth day, over-encapsulated capsule, oral (Treatment C)
Placebo
Over-encapsulation capsule, 4 days, oral (Treatment D)
Radiant Research, Inc., Pinellas Park
Radiant Research, Inc., Cincinnati
Radiant Research, Inc., Chicago
Radiant Research, Inc., San Antonio
Radiant Research, Inc., Chandler
Lead Sponsor
Bayer
INDUSTRY